R. G. Alken

687 total citations
31 papers, 480 citations indexed

About

R. G. Alken is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, R. G. Alken has authored 31 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Pharmacology. Recurrent topics in R. G. Alken's work include Plant-based Medicinal Research (5 papers), Ion channel regulation and function (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). R. G. Alken is often cited by papers focused on Plant-based Medicinal Research (5 papers), Ion channel regulation and function (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). R. G. Alken collaborates with scholars based in Germany, Czechia and France. R. G. Alken's co-authors include Rossen Koytchev, Norbert Rietbrock, Paul J. Schechter, Susanne Ramm, Jeffrey Grove, Klaus D. Haegele, Marcus Mannel, Gunnar Edman, L. Bjerkenstedt and Jan Koch‐Weser and has published in prestigious journals such as Pain, European Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

R. G. Alken

28 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. G. Alken Germany 12 105 93 69 61 58 31 480
Annil Mahajan India 15 62 0.6× 96 1.0× 66 1.0× 38 0.6× 24 0.4× 57 710
Alison N. Wadworth Switzerland 9 66 0.6× 99 1.1× 45 0.7× 96 1.6× 20 0.3× 10 537
Krishnananda Prabhu India 15 46 0.4× 148 1.6× 40 0.6× 31 0.5× 51 0.9× 62 634
Łukasz Dobrek Poland 13 36 0.3× 76 0.8× 37 0.5× 76 1.2× 41 0.7× 62 514
K. Schroecksnadel Austria 13 54 0.5× 177 1.9× 56 0.8× 29 0.5× 20 0.3× 17 704
Denis Lamiable France 16 168 1.6× 125 1.3× 48 0.7× 47 0.8× 9 0.2× 73 770
Massoumeh Shafiei Iran 17 75 0.7× 215 2.3× 33 0.5× 135 2.2× 41 0.7× 37 713
Supanimit Teekachunhatean Thailand 17 205 2.0× 177 1.9× 32 0.5× 27 0.4× 153 2.6× 53 828
R. Lambe Ireland 13 80 0.8× 92 1.0× 55 0.8× 55 0.9× 41 0.7× 43 614
Robert K. Drobitch United States 8 116 1.1× 148 1.6× 35 0.5× 13 0.2× 45 0.8× 12 478

Countries citing papers authored by R. G. Alken

Since Specialization
Citations

This map shows the geographic impact of R. G. Alken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. G. Alken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. G. Alken more than expected).

Fields of papers citing papers by R. G. Alken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. G. Alken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. G. Alken. The network helps show where R. G. Alken may publish in the future.

Co-authorship network of co-authors of R. G. Alken

This figure shows the co-authorship network connecting the top 25 collaborators of R. G. Alken. A scholar is included among the top collaborators of R. G. Alken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. G. Alken. R. G. Alken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmiedl, Sven, et al.. (2012). Cardiovascular effects, pharmacokinetics and cross-reactivity in digitalis glycoside immunoassays of an antidiarrheal uzara root extract. International Journal of Clinical Pharmacology and Therapeutics. 50(10). 729–740. 5 indexed citations
2.
Treese, N., Raimund Erbel, Catherine Diefenbach, et al.. (2008). Langzeittherapie der chronischen Herzinsuffizienz mit Enoximon. DMW - Deutsche Medizinische Wochenschrift. 112(30). 1163–1169.
3.
Rietbrock, N. & R. G. Alken. (2008). Die Therapie der Herzinsuffizienz mit Digitalis. DMW - Deutsche Medizinische Wochenschrift. 105(46). 1622–1628.
4.
Bjerkenstedt, L., Gunnar Edman, R. G. Alken, & Marcus Mannel. (2004). Hypericum extract LI 160 and fluoxetine in mild to moderate depression. European Archives of Psychiatry and Clinical Neuroscience. 255(1). 40–47. 51 indexed citations
5.
Koytchev, Rossen, et al.. (2003). Evaluation of the efficacy of a combined formulation (Grippostad®-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial. International Journal of Clinical Pharmacology and Therapeutics. 41(3). 114–125. 13 indexed citations
6.
Koytchev, Rossen, et al.. (1999). Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine. 6(4). 225–230. 59 indexed citations
7.
Koytchev, Rossen, et al.. (1998). Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol. European Journal of Clinical Pharmacology. 54(6). 469–474. 24 indexed citations
8.
Koytchev, Rossen, R. G. Alken, Oscar H. Mayer, A. Ian Smith, & Michael Greenwood. (1996). Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone - a novel antiarrhythmic agent. European Journal of Clinical Pharmacology. 50(4). 315–319. 4 indexed citations
9.
10.
Koytchev, Rossen, R. G. Alken, & Oscar H. Mayer. (1996). Effect of diprafenone on the pharmacokinetics of digoxin. European Journal of Clinical Pharmacology. 50(1-2). 97–100. 2 indexed citations
11.
Koytchev, Rossen, et al.. (1996). Absolute bioavailability of oral immediate and slow release fluphenazine in healthy volunteers. European Journal of Clinical Pharmacology. 51(2). 183–187. 5 indexed citations
12.
Mazur, Daniel J., et al.. (1995). Clinical And Urodynamic Effects of Propiverine in Patients Suffering from Urgency and Urge Incontinence. Scandinavian Journal of Urology and Nephrology. 29(3). 289–294. 45 indexed citations
13.
Koytchev, Rossen, R. G. Alken, & Erika Gromnica‐Ihle. (1994). Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew. Inflammation Research. 43(1-2). 48–52. 7 indexed citations
14.
Koytchev, Rossen, et al.. (1994). Differences in the bioavailability of dihydrotachysterol preparations. European Journal of Clinical Pharmacology. 47(1). 81–4. 1 indexed citations
15.
Koytchev, Rossen, et al.. (1994). [Absolute bioavailability of chlorpromazine, promazine and promethazine].. PubMed. 44(2). 121–5. 13 indexed citations
16.
Grove, Jeffrey, R. G. Alken, & Paul J. Schechter. (1984). Assay of γ-vinyl-γ-aminobutyric acid (4-amino-hex-5-enoic acid) in plasma and urine by automatic amino acid analysis. Journal of Chromatography B Biomedical Sciences and Applications. 306. 383–387. 24 indexed citations
17.
Haustein, Knut-Olaf, et al.. (1983). On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin. European Journal of Clinical Pharmacology. 25(3). 369–373. 5 indexed citations
18.
Alken, R. G., et al.. (1982). Differences in color vision deficiencies induced by various cardiac glycosides.. 1 indexed citations
19.
Rietbrock, Norbert & R. G. Alken. (1980). Color Vision Deficiencies. Journal of Cardiovascular Pharmacology. 2(1). 93–93. 26 indexed citations
20.
Rietbrock, N., et al.. (1979). [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].. PubMed. 29(11). 1742–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annil Mahajan Breakdown of academic impact, for papers by Alison N. Wadworth Breakdown of academic impact, for papers by Krishnananda Prabhu Breakdown of academic impact, for papers by Łukasz Dobrek Breakdown of academic impact, for papers by K. Schroecksnadel Breakdown of academic impact, for papers by Denis Lamiable Breakdown of academic impact, for papers by Massoumeh Shafiei Breakdown of academic impact, for papers by Supanimit Teekachunhatean Breakdown of academic impact, for papers by R. Lambe Breakdown of academic impact, for papers by Robert K. Drobitch
Rankless by CCL
2026